Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PureSilymarin Labs is a specialized biotechnology company and manufacturer focused on the production of high-purity milk thistle extract (silymarin). Founded in 2002, the company utilizes advanced extraction technologies, including supercritical CO2 and a patented two-step process, to achieve silymarin concentrations of up to 90-95%. Their pharmaceutical-grade extracts, such as the flagship SilyMax 80, are used in clinical trials and high-potency nutraceuticals targeting liver health and metabolic diseases. The company operates facilities certified to PIC/S GMP and ISO 22000 standards, serving global markets in North America, Europe, and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PureSilymarin Labs.